Byung Woog Kang

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study

Changhoon Yoo, Kyu‐pyo Kim, Jae Ho Jeong et al. · The Lancet Oncology · 2021 · 220 citations

Medicine, Oncology, Pharmacology +14

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer

Jaewon Hyung, Il Hwan Kim, Kyu‐pyo Kim et al. · JAMA Oncology · 2023 · 83 citations · Full text

Medicine, Oncology, Radiology +10

Quercetin-induced apoptosis prevents EBV infection

Minjung Lee, Myoungki Son, Eunhyun Ryu et al. · Oncotarget · 2015 · 80 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Han Sang Kim, Hyeong Ju Kwon, Inkyung Jung et al. · Clinical Cancer Research · 2014 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer

Hye Jin Kim, Gyu‐Seog Choi, Jun Seok Park et al. · Oncotarget · 2017 · 71 citations · Full text

Medicine, Oncology, Surgery +16